FRRS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.558200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.179000E-01
Normal-vs-Stage2
2.978800E-01
Normal-vs-Stage3
6.660000E-01
Normal-vs-Stage4
9.805800E-02
Stage1-vs-Stage2
6.374800E-01
Stage1-vs-Stage3
3.291800E-01
Stage1-vs-Stage4
2.027200E-01
Stage2-vs-Stage3
1.431600E-01
Stage2-vs-Stage4
1.677380E-01
Stage3-vs-Stage4
4.167900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.605600E-01
Normal-vs-AfricanAmerican
2.943600E-01
Normal-vs-Asian
5.584800E-01
Caucasian-vs-AfricanAmerican
3.363400E-01
Caucasian-vs-Asian
8.158600E-01
AfricanAmerican-vs-Asian
2.357600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.467800E-01
Normal-vs-Female
3.835200E-01
Male-vs-Female
4.006200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.323000E-01
Normal-vs-Age(41-60Yrs)
2.404000E-01
Normal-vs-Age(61-80Yrs)
4.412000E-01
Normal-vs-Age(81-100Yrs)
4.453200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.465400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.634600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.907600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.204400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.530800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.475800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.475000E-01
Normal-vs-Daily Drinker
6.809800E-01
Normal-vs-Weekly Drinker
6.013000E-01
Normal-vs-Occasional Drinker
2.404000E-01
Normal-vs-Social Drinker
4.802400E-01
Non Drinker-vs-Daily Drinker
4.613200E-01
Non Drinker-vs-Weekly Drinker
5.051800E-01
Non Drinker-vs-Occasional Drinker
1.252820E-01
Non Drinker-vs-Social Drinker
6.356000E-01
Daily Drinker-vs-Weekly Drinker
9.873800E-01
Daily Drinker-vs-Occasional Drinker
4.010200E-02
Daily Drinker-vs-Social Drinker
3.190200E-01
Weekly Drinker-vs-Occasional Drinker
5.156300E-02
Weekly Drinker-vs-Social Drinker
3.656600E-01
Occasional Drinker-vs-Social Drinker
4.312000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.797800E-01
Normal-vs-Grade 2
3.726200E-02
Normal-vs-Grade 3
6.499800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.982400E-02
Grade 1-vs-Grade 3
6.195000E-03
Grade 1-vs-Grade 4
3.797800E-01
Grade 2-vs-Grade 3
1.684430E-01
Grade 2-vs-Grade 4
3.726200E-02
Grade 3-vs-Grade 4
6.499800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.028000E-01
Normal-vs-NonDiabetic
3.843800E-01
Diabetic-vs-NonDiabetic
7.212000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.224600E-01
Normal-vs-NoPancreatitis
4.120400E-01
Pancreatitis-vs-NoPancreatitis
5.728800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.791800E-01
Normal-vs-N1
2.803800E-01
N0-vs-N1
5.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.810620E-01
Normal-vs-TP53-NonMutant
4.448400E-01
TP53-Mutant-vs-TP53-NonMutant
7.882500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
